IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome.
IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome.
复制标题
DOI:
10.1016/j.celrep.2022.111883
复制
发表时间:
2022-12-27
期刊:
影响因子:
8.8
通讯作者:
中科院分区:
文献类型:
--
作者:
Down syndrome (DS), the genetic condition caused by trisomy 21 (T21), is characterized by stunted growth, cognitive impairment, and increased risk of diverse neurological conditions. Although signs of lifelong neurodegeneration are well documented in DS, the mechanisms underlying this phenotype await elucidation. Here we report a multi-omics analysis of neurodegeneration and neuroinflammation biomarkers, plasma proteomics, and immune profiling in a diverse cohort of more than 400 research participants. We identified depletion of insulin growth factor 1 (IGF1), a master regulator of growth and brain development, as the top biosignature associated with neurodegeneration in DS. Individuals with T21 display chronic IGF1 deficiency downstream of growth hormone production, associated with a specific inflammatory profile involving elevated tumor necrosis factor alpha (TNF-α). Shorter children with DS show stronger IGF1 deficiency, elevated biomarkers of neurodegeneration, and increased prevalence of autism and other conditions. These results point to disruption of IGF1 signaling as a potential contributor to stunted growth and neurodegeneration in DS. Individuals with Down syndrome display stunted growth, chronic inflammation, and elevated signs of neurodegeneration across their lifespan. Araya et al. show that chronic deficiency in IGF1, a master regulator of human development, is associated with stunted growth, a specific inflammatory profile, and elevated signs of neurodegeneration in Down syndrome.
登录
查看更多内容
影响因子:
16.6
作者:
Ashton NJ;Janelidze S;Al Khleifat A;Leuzy A;van der Ende EL;Karikari TK;Benedet AL;Pascoal TA;Lleó A;Parnetti L;Galimberti D;Bonanni L;Pilotto A;Padovani A;Lycke J;Novakova L;Axelsson M;Velayudhan L;Rabinovici GD;Miller B;Pariante C;Nikkheslat N;Resnick SM;Thambisetty M;Schöll M;Fernández-Eulate G;Gil-Bea FJ;López de Munain A;Al-Chalabi A;Rosa-Neto P;Strydom A;Svenningsson P;Stomrud E;Santillo A;Aarsland D;van Swieten JC;Palmqvist S;Zetterberg H;Blennow K;Hye A;Hansson O
通讯作者:
Hansson O
影响因子:
5.2
作者:
Allard JB;Duan C
通讯作者:
Duan C
DOI:
10.1016/s1474-4422(21)00129-0
发表时间:
2021-08
期刊:
The Lancet. Neurology
影响因子:
--
作者:
Carmona-Iragui M;Alcolea D;Barroeta I;Videla L;Muñoz L;Van Pelt KL;Schmitt FA;Lightner DD;Koehl LM;Jicha G;Sacco S;Mircher C;Pape SE;Hithersay R;Clare ICH;Holland AJ;Nübling G;Levin J;Zaman SH;Strydom A;Rebillat AS;Head E;Blesa R;Lleó A;Fortea J
通讯作者:
Fortea J
影响因子:
25
作者:
Deliu, Elena;Arecco, Niccolo;Novarino, Gaia
通讯作者:
Novarino, Gaia
影响因子:
5.2
作者:
Annerén, G;Tuvemo, T;Gustafsson, J
通讯作者:
Gustafsson, J